Amar J. Majmundar

Amar J. Majmundar

Auto-generated profile, based on publicly available information

Amar J. Majmundar

Division of Nephrology, Boston Children's Hospital, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2019 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
ITIrit Tirosh
Irit Tirosh
SSShiri Spielman
Shiri Spielman
OBOrtal Barel
Ortal Barel
RRReut Ram
Reut Ram
TSTali Stauber
Tali Stauber
AVAsaf Vivante
Asaf Vivante
Systemic lupus erythematosus (SLE) comprise a diverse range of clinical manifestations. To date, more than 30 single gene causes of lupus/lupus like syndromes in humans have been identified. In the clinical setting, identifying the underlying molecular diagnosis is challenging due to phenotypic and genetic heterogeneity. We employed whole exome sequencing (WES) in patients presenting with childhood-onset lupus with severe and/or atypical presentations to identify cases that are explained by a single-gene (monogenic) cause. From January 2015 to June 2018 15 new cases of childhood-onset SLE were diagnosed in Edmond and Lily Safra Children’s Hospital. By WES we identified causative mutations in four subjects in five different genes: C1QC, SLC7A7, MAN2B1, PTEN and STAT1. No molecular diagnoses were established on clinical grounds prior to genetic testing. We identified a significant fraction of monogenic SLE etiologies using WES and confirm the genetic locus heterogeneity in childhood-onset lupus. These results highlight the importance of establishing a genetic diagnosis for children with severe or atypical lupus by providing accurate and early etiology-based diagnoses and improving subsequent clinical management.

1 January 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
AMAmar J. Majmundar
Amar J. Majmundar
FBFlorian Buerger
Florian Buerger
TFThomas Alexander Forbes
Thomas Alexander Forbes
VKVerena Klämbt
Verena Klämbt
RSRonen Schneider
Ronen Schneider
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt
NOS1AP variants impair actin remodeling in podocytes and cause glomerular disease in humans, kidney organoids, and mice.

1 March 2025 in Genes & Diseases
Verified
Journal Article
Open access
RSRonen Schneider
Ronen Schneider
SSShirlee Shril
Shirlee Shril
FBFlorian Buerger
Florian Buerger
KDKonstantin Deutsch
Konstantin Deutsch
KYKirollos Yousef
Kirollos Yousef
FHFriedhelm and Sabine Hildebrandt
Friedhelm and Sabine Hildebrandt

27 November 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
FBFlorian Buerger
Florian Buerger
DSDaanya Salmanullah
Daanya Salmanullah
LLLorrin Liang
Lorrin Liang
VGVictoria Gauntner
Victoria Gauntner
KKKavita Krueger
Kavita Krueger
AMAmar J. Majmundar
Amar J. Majmundar
In genetic disease, an accurate expression landscape of disease genes and faithful animal models can facilitate genetic diagnoses and therapeutic advances respectively. Previously, we found that variants in NOS1AP, the gene that encodes nitric oxide synthase 1 adaptor protein, cause monogenic nephrotic syndrome. Here, we determine that an intergenic splice product of NOS1AP/Nos1ap and neighboring C1orf226/Gm7694, which prevents NOS1AP from binding to nitric oxide synthase 1, is the predominant isoform in mammalian kidney transcriptional and proteomic data. Gm7694−/− mice, whose allele exclusively disrupts the intergenic product, develop nephrotic syndrome phenotypes. In two male human subjects with nephrotic syndrome, we identify causative NOS1AP splice variants, including one predicted to abrogate intergenic splicing but initially misclassified as benign based on the canonical transcript. Finally, by modifying genetic background, we generate a faithful mouse model of NOS1AP-associated monogenic nephrotic syndrome that responds to anti-proteinuric treatment.

9 February 2022 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
RHReema Habiby
Reema Habiby
DBDaniel G Bichet
Daniel G Bichet
MAMarie-Francoise Arthus
Marie-Francoise Arthus
DCDervia Connaughton
Dervia Connaughton
SSShirlee Shril
Shirlee Shril
GRGary L Robertson
Gary L Robertson
Context: Familial pituitary diabetes insipidus has been described only in an autosomal dominant or recessive mode of inheritance. Objective: This work aims to determine the cause of a novel form of familial diabetes insipidus (DI) that is controlled by desmopressin therapy but segregates in an X-linked recessive manner. Methods: Thirteen members from 3 generations of the kindred with familial DI were studied. Water intake, urine volume, urine osmolality, plasma osmolality, and plasma vasopressin were measured under basal conditions, during fluid deprivation, 3% saline infusion, and water loading. Magnetic resonance images of the posterior pituitary also were obtained. In affected males, the effects of desmopressin therapy and linkage of the DI to markers for chromosome Xq28 were determined. In addition, the genes encoding vasopressin, aquaporin-2, the AVPR2 receptor, and its flanking regions were sequenced. Results: This study showed that 4 males from 3 generations of the kindred have DI that is due to a deficiency of vasopressin, is corrected by standard doses of desmopressin, and segregates with markers for the AVPR2 gene in Xq28. However, no mutations were found in AVPR2 or its highly conserved flanking regions. Exome sequencing confirmed these findings and also revealed no deleterious variants in the provasopressin and aquaporin-2 genes. The 4 obligate female carriers osmo-regulated vasopressin in the low normal range. Conclusion: X-linked recessive transmission of DI can be due to a defect in either the secretion or the action of vasopressin. Other criteria are necessary to differentiate and manage the 2 disorders correctly.

21 March 2024 in medRxiv
Verified
Preprint
Open access
PDF file
FBFlorian Buerger
Florian Buerger
DSDaanya Salmanullah
Daanya Salmanullah
LLLorrin Liang
Lorrin Liang
VGVictoria Gauntner
Victoria Gauntner
KKKavita Krueger
Kavita Krueger
AMAmar J. Majmundar
Amar J. Majmundar
In genetic disease, an accurate expression landscape of disease genes and faithful animal models will enable precise genetic diagnoses and therapeutic discoveries, respectively. We previously discovered that variants in NOS1AP , encoding nitric oxide synthase 1 (NOS1) adaptor protein, cause monogenic nephrotic syndrome (NS). Here, we determined that an intergenic splice product of N OS1AP / Nos1ap and neighboring C1orf226/Gm7694 , which precludes NOS1 binding, is the predominant isoform in mammalian kidney transcriptional and proteomic data. Gm7694 -/- mice, whose allele exclusively disrupts the intergenic product, developed NS phenotypes. In two human NS subjects, we identified causative NOS1AP splice variants, including one predicted to abrogate intergenic splicing but initially misclassified as benign based on the canonical transcript. Finally, by modifying genetic background, we generated a faithful mouse model of NOS1AP -associated NS, which responded to anti-proteinuric treatment. This study highlights the importance of intergenic splicing and a potential treatment avenue in a mendelian disorder.